Stephen Leslie
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Alnylam Pharmaceuticals Inc. accounts for 80.2% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2019 at $5,953 and has fallen 99.0% since, to $57 in 2024.
Across 88 payments — averaging $131.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$9K
- Astellas Pharma US Inc$572
- AbbVie$274
- Merck$134
- Dornier Medtech America, Inc$116
- Boston Scientific$115
- plus $1K from 24 others
What the payments were for
- Consulting fees$4,84042%
- Travel & lodging$4,29237%
- Food & beverage$1,98017%
- Education$4584%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 7 | $9,280 |
| Astellas Pharma US Inc | 10 | $572 |
| AbbVie(2 entities) | 17 | $274 |
| Merck | 3 | $134 |
| Dornier Medtech America, Inc | 1 | $116 |
| Boston Scientific | 2 | $115 |
| KARL Storz Endoscopy-america | 3 | $105 |
| Tolmar Pharmaceuticals, Inc. | 6 | $100 |
| Johnson & Johnson(2 entities) | 2 | $97 |
| Pfizer | 4 | $91 |
| Dendreon Pharmaceuticals LLC | 3 | $85 |
| Amgen | 6 | $85 |
| Insulet Corporation | 2 | $67 |
| Agiliti Surgical, Inc. | 1 | $49 |
| Photocure Inc | 1 | $47 |
| Coloplast | 2 | $41 |
| Travere Therapeutics, Inc. | 2 | $38 |
| Blue Earth Diagnostics | 2 | $36 |
| Endo Pharmaceuticals Inc. | 2 | $34 |
| Bayer | 2 | $33 |
| Rochester Medical Corporation | 1 | $27 |
| 180 Medical, Inc. | 1 | $25 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Myovant Sciences Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $13 |
| Ambu Inc. | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ONPATTRO$4,840
- MYRBETRIQ$125
- Lithotripters & Accessories$116
- GIVLARRI$104
- KEYTRUDA$100
How this compares
$11,570 in reported general payments places this provider in the 80th percentile of 79 urology providers in Nebraska.
Other urology in Omaha
- John BishayOmaha$138K
- Rebecca McCreryOmaha$71K
- Judson DaviesOmaha$67K
- Stefanie BolteOmaha$59K
- Michael FeloneyOmaha$29K
- Andrew TrainerOmaha$12K
- Jon MortonOmaha$11K
- Brett HillOmaha$11K
- John HorganOmaha$10K
- Larry SirefOmaha$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.